McKesson Canada
In 1991, McKesson Corporation acquired a 100 percent interest in Medis Health and Pharmaceutical Services from Provigo. In 2002, the McKesson Canada name was adopted. McKesson Canada is a wholly owned subsidiary of McKesson Corporation. It includes various business units: McKesson Pharmaceutical, McKesson Automation, McKesson Specialty, McKesson Health Solutions, and McKesson Information Solutions.
In 2012, McKesson agreed to purchase Canadian pharmacy chains IDA, Guardian Pharmacy, and The Medicine Shoppe from the Katz Group of Companies for $920 million.[57]
In March 2016, McKesson agreed to purchase Canadian pharmacy chain Rexall from the Katz Group of Companies for $3 billion.[58] The deal was finalized in December 2016 following approval received under the Investment Canada Act.[59]
On April 12, 2017, it was announced that McKesson Canada reached a deal to acquire 330 Uniprix pharmacies.[60]
In May 2018, McKesson Canada closed 40 Rexall locations in Ontario and Western Canada.[61]
United Kingdom
In the United Kingdom, McKesson, operating as McKesson Information Solutions UK Ltd, was a provider of information technology services to the healthcare industry. In addition to numerous clinical software systems and finance and procurement services, McKesson also was responsible for developing the Electronic Staff Record system for the National Health Service which provided an integrated payroll system for NHS's 1.3 million staff, making it the world's largest single payroll IT system. McKesson Shared Services also provided payroll services for over 20 NHS Trusts, paying over 100,000 NHS members.
McKesson's United Kingdom base was in Warwick with data centers in Newcastle upon Tyne and Brent Cross and offices in Sheffield, Bangor, Glasgow and Vauxhall, London. Across the United Kingdom, it employed over 500 people.
In 2014, McKesson sold most of their healthcare software business to the private equity firm Symphony Technology Group and indicated also that they would not be re-bidding for the Electronic Staff Record contract.[62][63] This came after the company had posted significant year on year losses in revenue (16% in the 2012/13 financial year[64]
Australia and New Zealand
In 2010, McKesson Asia-Pacific was acquired by Medibank Private Ltd.[67][68]
McKesson ANZ is a fully owned subsidiary of McKesson Corporation. McKesson expanded its footprint in Australia and New Zealand by acquiring Emendo in November 2012.[69] McKesson ANZ develops and sells healthcare optimization services and software. The company has traditionally been focused on the public markets in Australia and New Zealand. The majority of the District Health Boards in NZ use one or more of McKesson's Capacity Management solutions.
Christchurch in New Zealand, is one of McKesson's global Capacity Management R&D centers of excellence. All of McKesson's R&D for McKesson Capacity Planner is performed in New Zealand. The company employs approximately 40 team members across Australia and New Zealand, including general management, R&D, sales, services, and support employees.
McKesson Capacity Planne, formerly Emendo CapPlan, is used in more than 40 hospitals in Australia, New Zealand, Britain, Canada, and the US[70]
Germany
On November 2, 2020, Walgreens Boots Alliance (WBA) and McKesson announced the completion of their previously announced agreement to create a joint venture combining their respective pharmaceutical wholesale businesses in Germany, Alliance Healthcare Deutschland (AHD) and GEHE Pharma Handel (GEHE). WBA holds a 70 percent controlling equity interest in the joint venture and McKesson holds the remaining 30 percent interest.[72]
